Studies have shown that about 70% of individuals experience significant weight loss, which is generally an added benefit rather than a guaranteed outcome
Human evidence is limited
He was on a GLP-1 for about two years and lost about 40 pounds
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
86 DRAM1 participates in the regulation of autophagy and apoptosis in intestinal epithelial cells by positively regulating JNK, and knockdown of DRAM1 can lead to a decrease in the phosphorylation levels of c-Jun and JNK, inhibit the formation of autophagosomes, and alleviate the symptoms of UC
Biologic agents targeting TNF- (such as adalimumab, etanercept, infliximab), IL-17 (secukinumab, ixekizumab), or IL-23 (guselkumab, risankizumab) work via immune modulation and do not share metabolic pathways with tirzepatide